New Study Finds Atherosclerosis Meets Defining Criteria of an Autoimmune Disease
Atherosclerosis meets the criteria for an autoimmune disease, according to a new study of mice and patients published in Nature Cardiovascular Research by an international research consortium. In classic autoimmune diseases like Multiple Sclerosis, Type 1 Diabetes, and Rheumatoid Arthritis, the immune system turns against the body through pathogenic B cells or T cells, resulting in severe organ damage. While researchers have debated the exact mechanisms for decades, the new findings show that atherosclerosis satisfies these crucial defining criteria.
The research was directed by Professor Andreas Habenicht at LMU University Hospital and Professor Changjun Yin at Sun-Yat-Sen University in Guangzhou, China. According to the study, investigators identified high-affinity autoreactive antibodies that accelerate atherosclerosis when transferred into mice. One specific autoantibody identified by the team targets histone 2B. When researchers vaccinated mice with histone 2B, the severity of atherosclerosis increased.
Clinical Trial Data and Future Diagnostics
To substantiate the experimental data gathered in mice, the research team evaluated clinical data from a trial involving 495 patients from the general population recruited in Guangzhou, according to the study. Professor Habenicht stated that the data are likely to have transformative power because they characterize atherosclerosis as an autoimmune disease. He added that the findings have fundamental implications for future research by enabling the development of new diagnostics and immunotherapeutics before patients suffer myocardial infarctions and strokes. At the same time, Professor Habenicht offered a cautionary note, stating that the study provides only a glimpse into a long and challenging journey.
Did you know?
Type 1 Diabetes acts as a strong risk factor for atherosclerosis, requiring lifelong treatment, according to the research consortium.
Comparing Autoimmune and Non-Autoimmune Inflammatory Drivers
For decades, standard narratives for non-autoimmune atherosclerosis emphasized a multi-factorial, chronic inflammatory process driven by risk factors like dyslipidemia and vascular injury. According to background data, oxidized low-density lipoprotein (oxLDL) plays a pivotal role by entering the arterial intima, activating endothelial cells, and recruiting circulating leukocytes. Monocytes and macrophages then ingest oxLDL to form foam cells, which secrete further inflammatory mediators. While earlier models focused heavily on innate immune responses and inflamsemate activation like IL-1 cytokines, the new findings from the LMU and Sun-Yat-Sen University consortium bridge a critical gap by confirming the presence of pathogenic adaptive immune drivers, specifically high-affinity autoantibodies.
Frequently Asked Questions
Is atherosclerosis officially classified as an autoimmune disease?
According to research published in Nature Cardiovascular Research by Professor Andreas Habenicht and Professor Changjun Yin, new findings demonstrate that atherosclerosis satisfies crucial defining criteria of an autoimmune disease.
What autoantibody was linked to accelerated atherosclerosis in the study?
Researchers identified high-affinity autoreactive antibodies, including one specifically directed against histone 2B, which accelerated the severity of atherosclerosis following vaccination in mouse models.
How many patients were included in the clinical trial portion of the study?
The clinical trial evaluated 495 patients from the general population recruited in Guangzhou, according to the published findings.
What are your thoughts on this paradigm shift in cardiovascular research? Share your perspective in the comments below, explore our related health articles, or subscribe to our newsletter for the latest medical updates.
Related reading